| Ytd | -73.10% | |
| 1y | -59.58% |
| Open | 0.31 | Prev Close | 0.31 | Low | 0.29 | High | 0.31 | Mkt Cap | 14.76M |
| Vol | 507.91K | Avg Vol | 2.58M | EPS | -4.55 | P/E | N/A | Forward P/E | -0.84 |
| Beta | 0.40 | Short Ratio | 1.60 | Inst. Own | 33.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.39 | 200-d Avg | 0.83 | 1yr Est | 5.00 |
AEON News
ALISO VIEJO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”
Gainers Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regul
AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical comp
- Former Deputy Director of the FDA's Office of Neuroscience - Dr. Lee has previously advised AEON
Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market s
- Complementary peptide-mapping methods increased coverage of the active botulinum neurotoxin primar
- Complementary peptide-mapping methods increased coverage of the active botulinum neurotoxin primar
Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's aft
HC Wainwright & Co. analyst Douglas Tsao maintains AEON Biopharma (AMEX:AEON) with a Buy and
AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.02) per share which beat the analyst con
- Executed a $15.3 million financing with milestone warrants providing potential for an additional $
AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical comp
ALISO VIEJO, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's
VICTORIA, Seychelles, July 27, 2026 (GLOBE NEWSWIRE) -- Bitget , the world's largest Universal Excha
Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's
Shares of Aehr Test Systems (NASDAQ: AEHR) jumped 29.6% to $93.30 in pre-market trading. Aehr Test
$13.75 million underwritten public offering with up to an additional $29.6 million in potential proc
Vision Marine Technologies Inc (NASDAQ: VMAR) gained 60.3% to $2.26 in pre-market trading after repo
Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's
AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical comp
IRVINE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NY
AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.29) per share which missed the analyst c
- Reported positive FDA Type 2a meeting supporting ABP-450's comparative analytical strategy under t
- Annual Shareholder Meeting to be held at 10:00 am PT on June 17, 2026 - IRVINE, Calif. , April 24,
Aerovate Therapeutics (NASDAQ: AVTE - Get Free Report) and AEON Biopharma (NASDAQ: AEON - Get Free R
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (N
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (N
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytic
AEON Biopharma (NASDAQ: AEON - Get Free Report) is anticipated to release its results before the mar
AEON Biopharma (NASDAQ: AEON - Get Free Report) and MindWalk (NASDAQ: HYFT - Get Free Report) are bo
- AEON confirmed that earlier today it held its BPD Type 2a Meeting with the FDA, in line with prior
AEON Biopharma (NASDAQ: AEON - Get Free Report) and Merck KGaA (OTCMKTS:MKGAF - Get Free Report) are
IRVINE, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NY